A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1997
12/11/1997	WO1997046522A1 Novel vitamin d analogues
12/11/1997	WO1997046521A1 Nitrate esters and their use for neurological conditions
12/11/1997	WO1997046511A1 Coumpounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
12/11/1997	WO1997046257A1 A method for enhancing long-term memory in a subject and uses thereof
12/11/1997	WO1997046251A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
12/11/1997	WO1997046234A1 Pharmaceutical compositions containing mesembrine and related compounds
12/11/1997	WO1997041443A3 Method for screening compounds
12/11/1997	WO1997040017A3 Modulators of molecules with phosphotyrosine recognition units
12/11/1997	CA2257424A1 Neuropeptide y agonists
12/11/1997	CA2257206A1 Oxadiazole benzenesulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
12/11/1997	CA2257074A1 A method for enhancing long-term memory in a subject and uses thereof
12/11/1997	CA2256456A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	CA2256449A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
12/10/1997	EP0811623A1 Xanthine derivatives with end-aminated alkynol side chains
12/10/1997	EP0811622A1 3-(Piperi-4-yl) 1,2-benzisoxazole and 3-(piperazin-4-yl) 1,2-benzisoxazole derivatives, processes for their preparation and pharmaceutical compositions containing them
12/10/1997	EP0811386A2 Method of selecting a salt for making an inclusion complex
12/10/1997	EP0811011A1 Carbohydrate conjugated bio-active compounds
12/10/1997	EP0811002A2 Benzylpiperidines and piperazines as muscarinic antagonists
12/10/1997	EP0810991A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
12/10/1997	EP0810879A1 Preparation and use of a specific gaba-aalpha5 receptor ligand for treatment of alzheimer's disease
12/10/1997	EP0810863A1 Method of treating adenosine depletion
12/10/1997	EP0810859A1 Method of treatment of traumatic brain injury
12/10/1997	EP0674625B1 Amino-substituted pyrazoles having crf antagonistic activity
12/10/1997	CN1167489A Novel estrenes for inducing hypothalamic effects
12/10/1997	CN1167487A Oxazolyl-and thiazolylimidazo- and thienodiazepines and their use as medicaments
12/10/1997	CN1167482A Novel carbamate compounds containing thiocarbamoyl group and process for preparing the same
12/10/1997	CN1167441A New Therapeutical utilization of superoxide dismutases
12/10/1997	CN1167107A Method of preparing enantiomers of O-demethyltramadol
12/10/1997	CN1036653C Heterocyclic ring spiroring compounds and process for preparing same
12/10/1997	CN1036652C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
12/09/1997	US5696267 Substituted oximes, hydrazones and olefins as neurokinin antagonists
12/09/1997	US5696260 Certain cycloalkyl imidazopyrimidines, a new class of gaba brain receptor ligands
12/09/1997	US5696165 Composition of s(-) sodium ibuprofen
12/09/1997	US5696149 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders
12/09/1997	US5696145 Vasopressin and oxytocin receptor
12/09/1997	US5696142 Aminoalkyloximes
12/09/1997	US5696138 Urea derivatives and their use
12/09/1997	US5696137 Azaheterocyclymethyl-chromans
12/09/1997	US5696136 Method of treating psychosis using azaheterocyclylmethyl
12/09/1997	US5696135 Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
12/09/1997	US5696129 5-HT4 antagonists
12/09/1997	US5696126 Prodrug esters of phenolic 2-piperidino-1-alkanols
12/09/1997	US5696124 Xanthine derivatives with adenosine-antagonistic activity
12/09/1997	US5696122 Indole and indoline derivatives as 5HT1D receptor antagonists
12/09/1997	US5696113 Antipsychotic agents, compositions and method of use
12/09/1997	US5696108 Protein kinase C inhibitors
12/09/1997	US5696077 Pharmaceutical composition containing botulinum B complex
12/09/1997	US5695995 Neurogenic differentiation (neurod) genes
12/09/1997	US5695782 Double-layered oxcarbazepine tablets
12/09/1997	US5695774 Use of nabumetone or 6-methoxynaphthyl acetic acid for the treatment of dementia
12/09/1997	CA2135922C Quick-change tool holder with center-height adjustment mechanism
12/09/1997	CA2131365C Epibatidine and derivatives, compositions and methods of treating pain
12/09/1997	CA2126210C Process for preparing flunixin and intermediates thereof
12/09/1997	CA2075181C 4,5-bridged-2,3,4,5-tetrahydro-1h-3-benzazepine-7-ols
12/09/1997	CA2058935C Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
12/04/1997	WO1997045746A2 Prion protein binding proteins and uses thereof
12/04/1997	WO1997045426A1 Azetidine, pyrrolidine and piperidine derivatives as 5-ht1d receptor agonists
12/04/1997	WO1997045425A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
12/04/1997	WO1997045423A1 Pharmaceutical for treating of neurological and neuropsychiatric disorders
12/04/1997	WO1997045419A1 Benzoxazinone dopamine d4 receptor antagonists
12/04/1997	WO1997045417A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
12/04/1997	WO1997045416A1 NEW DERIVATIVES OF 10,11-DIHYDRO-10-OXO-5H-DIBENZ/b,F/AZEPINE-5-CARBOXAMIDE
12/04/1997	WO1997045409A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
12/04/1997	WO1997045403A1 Aryl substituted cyclic amines as selective dopamine d3 ligands
12/04/1997	WO1997045135A1 Stable pharmaceutical composition of bdnf
12/04/1997	WO1997045125A1 USE OF ESTROGEN TO MODIFY THE AMOUNT OF SEROTONIN TRANSPORTER OR ITS mRNA
12/04/1997	WO1997045124A1 Pharmaceutical compositions
12/04/1997	WO1997045115A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/04/1997	WO1997045107A1 Remedies for brain diseases
12/04/1997	WO1997037689A3 Denaturants for sympathomimetic amine salts
12/04/1997	WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
12/04/1997	CA2619901A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/04/1997	CA2256312A1 Prion protein binding proteins and uses thereof
12/04/1997	CA2255727A1 Pharmaceutical for treating of neurological and neuropsychiatric disorders
12/04/1997	CA2255696A1 Azetidine, pyrrolidine and piperidine derivatives as 5-ht1d receptor agonists
12/04/1997	CA2255612A1 Aryl substituted cyclic amines as selective dopamine d3 ligands
12/04/1997	CA2254339A1 Use of estrogen to modify the amount of serotonin transporter or its mrna
12/04/1997	CA2253406A1 Benzoxazinone dopamine d4 receptor antagonists
12/04/1997	CA2227811A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
12/03/1997	EP0810225A1 Process for producing paroxetine
12/03/1997	EP0810220A1 Arylacrylamide derivatives as 5HT1 agonists or antagonists
12/03/1997	EP0810218A1 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II)
12/03/1997	EP0810216A1 Derivatives of 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide
12/03/1997	EP0809701A1 Calcineurin regulatable adenylate cyclase
12/03/1997	EP0809656A1 MONOCLONAL ANTIBODY SPECIFIC FOR $g(b)A4 PEPTIDE
12/03/1997	EP0809642A1 Imidazo 1,2-a]pyridines for the treatment of cns and cardiac diseases
12/03/1997	EP0809641A1 Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
12/03/1997	EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997	EP0809635A1 Alpha-substituted hydrazides having calpain inhibitory activity
12/03/1997	EP0809630A1 Indole derivatives with affinity for the cannabinoid receptor
12/03/1997	EP0809624A1 Alkylcarboxy amino acids-modulators of the kainate receptor
12/03/1997	EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997	EP0809495A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders
12/03/1997	EP0809494A1 The use of heterocyclic compounds
12/03/1997	EP0717733B1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
12/03/1997	EP0691960B1 Antipsychotic benzimidazole derivatives
12/03/1997	EP0689539B1 Antipsychotic indazole derivatives
12/03/1997	CN1166785A Pharmaceutical control of inflammation
12/03/1997	CN1166490A Prep of novel mercaptoacetylamide derivatives
12/03/1997	CN1036590C Process for preparation of mercaptoacetylamide derivatives

1 ... 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 ... 1833